# Prophylactic Treatment With Atorvastatin for Episodic Migraine.

> **NCT06248671** · PHASE2 · RECRUITING · sponsor: **St. Olavs Hospital** · enrollment: 450 (estimated)

## Conditions studied

- Episodic Migraine

## Interventions

- **DRUG:** Atorvastatin 40mg
- **DRUG:** Placebo
- **DRUG:** Atorvastatin 20mg

## Key facts

- **NCT ID:** NCT06248671
- **Lead sponsor:** St. Olavs Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-05-01
- **Primary completion:** 2028-12-31
- **Final completion:** 2029-02-28
- **Target enrollment:** 450 (ESTIMATED)
- **Last updated:** 2026-02-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06248671

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06248671, "Prophylactic Treatment With Atorvastatin for Episodic Migraine.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06248671. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*